SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent introduced the SureSelect Human All Exon v2 Target Enrichment kit, which was developed in close collaboration with the Broad Institute of MIT and Harvard.
For more information, please visit
http://www.businesswire.com/news/home/20100824005973/en